The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market. They are as follows:

• Smith & Nephew
• Stryker
• Zimmer Biomet
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• NuVasive, Inc.
• Medtronic
• Integra LifeSciences
• Wright Medical Group N.V.
• Össur Corporate
• Globus Medical
• Other prominent players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthopedic-devices-market-102586

This Report Answers the Following Questions:

• What are the orthopedic medical devices market trends?
• How many opportunities and challenges would the market come across in the near future?
• What are the growth drivers and barriers that the market is likely to face?
• How many segments are present in the market?
• Which companies would generate the highest share during the forecast period?
• Which region is set to remain dominant?

Drivers & Restraints-

Rising Prevalence of Musculoskeletal Diseases to Drive Growth

The American Academy of Orthopedic Surgeons, a provider of educational programs for allied health professionals and orthopaedic surgeons, published a report that affirms that every year in the Unites States alone, approximately 6.8 million patients suffering from several orthopedic injuries come to medical attention. It proves that the rising prevalence of orthopedic injuries and musculoskeletal diseases is further resulting in agonizing physical pain and limited mobility. It is expected to propel the orthopedic devices market growth during the forthcoming years. However, the surgical procedure is very expensive in nature. It may hamper the growth of the market.

The global sleep apnea treatment devices market size is set to touch USD 8.97 billion by 2026, exhibiting a CAGR of 8.2% during the forecast period. Steadily climbing demand for sleep apnea devices, stemming from a consistent spread in the prevalence of sleep apnea, will be a major growth driver for this market, shares Fortune Business Insights™ in its new report, titled “Sleep Apnea Treatment Devices Market Size, Share & Industry Analysis, By Device Type (Positive Airway Pressure (PAP) Devices, Oral Appliances, Masks & Accessories, and Others), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/sleep-apnea-treatment-devices-market-102694

List of Players Covered in the Report:

• Braebon Medical Corporation
• Glidewell
• Oventus
• Fisher & Paykel Healthcare Limited
• ResMed
• DeVilbiss Healthcare
• BMC Medical Co., Ltd.
• SomnoMed
• Koninklijke Philips N.V.

A study published in the medical journal Lancet in 2019 found that nearly 1 billion people worldwide suffer from Obstructive Sleep Apnea (OSA). Regionally, too, the statistics conform to the global trends. For instance, the European Respiratory Society estimates that 13% to 32% of the geriatric population in Europe suffer from sleep apnea. As a result, the demand for sleep apnea treatment is escalating and driving the sleep apnea treatment devices market trends. Furthermore, the incidence of OSA is spiking owing to the rising prevalence of obesity, the most common cause for interrupted sleep, which according to the World Health Organization, presently affects close to 650 million adults worldwide.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sleep-apnea-treatment-devices-market-102694

According to the report, the value of the market stood at USD 4.82 billion in 2018. The report further contains:

• Thorough analysis of the factors and trends driving and restraining the market;
• Comprehensive research into the regional and competitive dynamics of the market;
• Detailed segmentation of the market and in-depth evaluation of the individual market segments; and
• Precise computation of market figures and values.

Regional Analysis

Availability of Advanced Treatment Options to Propel the Market in North America

With a market size of USD 2.35 billion in 2018, North America is poised to dominate the sleep apnea treatment devices market share during the forecast period. The key factors augmenting this regional market include wide availability and high adoption of advanced products, along with growing prevalence of sleep disorders among the populace. In addition to this, supportive health insurance and reimbursement policies are further fueling the uptake of these devices in the region.

In Asia-Pacific, the major driving force for the market is the rising demand for sleep apnea therapies in Japan and the presence of a large, underpenetrated market in the rest of the region. These factors are expected to aid Asia-Pacific to register a considerable CAGR in the upcoming years.

The Global Burden of Disease Study has found that around 251 million people in the world were affected by Chronic Obstructive Pulmonary Disease or COPD in 2016. This will fuel demand for nebulizers, driving the global nebulizers market. The above information was shared by Fortune Business Insights in a report, titled “Nebulizers Market Size, Share and Global Trend By Product (Pneumatic Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Others), By End-User (Clinics, Hospitals, Ambulatory Surgery Centres, Home Care Settings, Others), and Geography Forecast till 2026.” A nebulizer is a medical device which helps to treat asthma by converting different drugs into vapours and later delivering it to the lungs. Not only asthma, but nebulization also helps in the treatment of other respiratory disorders such as cystic fibrosis. 

The demand for different types of nebulizer products such as ultrasonic nebulizers, pneumatic nebulizers, mesh nebulizers, and others is increasing. Of these, a pneumatic nebulizer was leading the global market and is anticipated to maintain its dominance through the forecast years. The rising prevalence of respiratory disorders especially among the aged population is driving the segment’s growth. Considering this, the global nebulizers market share is expected to increase in the forecast years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707

some of the key players in the Global Nebulizers Market:

• OMRON Corporation
• Koninklijke Philips N.V.
• PARI
• Becton
• Dickinson and Company
• Allied Healthcare
• Agilent Technologies, Inc.
• Medline Industries, Inc.
• Briggs Healthcare

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nebulizers-market-100707

Market Sees Growth Owing to Rising Adoption of Technologically-advanced Medical Devices in North America

Rising geriatric population in North America is resulting in an increasing number of surgeries and respiratory diseases. This will boost the nebulizers market size in North America. As per a study conducted by the Center for Diseases Control and Prevention, people in the U.S. suffered deaths in 2014, as COPD was the third-leading disease for these deaths. The market was leading in the year 2018 on account of mounting pollution levels and increasing healthcare expenditure. Another factor responsible for growth is the rising adoption of technologically-advanced medical devices and equipment.

The market in Asia Pacific is expected to grow considerably during the forecast period. Increasing cases of respiratory disorders and rising geriatric population are primary factors enabling growth in the market. Countries such as India and China have high pollution levels, which increases the prevalence of respiratory diseases. Enabled by this, the demand for nebulizer machines is increasing in Asia Pacific. This will further positively impact nebulizers market growth. Rising disposable income among people and growing awareness about diseases in this region are potential growth triggers in the market. As per the Institute for Health Metrics and Evaluation, the number of COPD cases in Japan increased by 24.2% between 2005 and 2016. Hence, the rising prevalence of respiratory disorders is expected to drive the nebulizers market size in Asia Pacific.

The global wound care market size is projected to showcase significant progress and earn USD 24.55 billion by 2027. This is accountable to the increasing prevalence of chronic diseases such as diabetes, blood pressure, and the wounds that result from them, such as diabetic foot ulcers and pressure ulcers. Wound care is used for injuries that are unable to heal by themselves. If untreated, they may result in severe consequences, such as mobility issues, decreased elasticity of blood vessels, and others. A recent report by Fortune Business Insights offers an elaborative overview of the market. The report is titled, “Wound Care Market Size, Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027.” According to this report, the market value stood at USD 15.68 billion in 2019 and is likely to exhibit a CAGR of 6.0% between 2020 to 2027.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wound-care-market-103268

As per a report by Fortune Business Insights™, some of the significant players in the market are as follows:

• Johnson & Johnson Services, Inc.
• Smith & Nephew
• Coloplast Corp
• Cardinal Health
• ConvaTec Inc.
• Medtronic
• 3M
• BSN Medical (Essity)
• PAUL HARTMANN AG
• Other players

The worldwide pandemic of COVID-19 has shaken the world economy. Most businesses are at a halt, import-export is not possible, and the entire world is hoping to come out of this situation. With government support and necessary measures, we soon hope to overcome this situation and step into a better tomorrow. We, at Fortune Business Insights, are offering special reports on various markets impacted by the coronavirus pandemic and its future objectives. These reports will help investors study the market thoroughly and accordingly chalk out business strategies for generating future revenues.

Click here to get the short-term and long-term impacts of COVID-19 on this Market.

Please visit: 

https://www.fortunebusinessinsights.com/wound-care-market-103268

The report is based on the following questions:

• What is the nature of the market?
• Which is the leading segment?
• Who is the leading player of the wound care market?
• How is the prevalence of diabetes aiding in the expansion of the market?
• What are the key developments of the market?

Drivers & Restraints-

Increasing Popularity of Bioactive Therapy to Add Impetus to Market

The rising prevalence of acute and chronic diseases such as diabetic foot ulcers, pressure ulcers, and others are some of the key factors promoting this market growth. This, coupled with the advent and adoption of technologically advanced wound care products, will also add impetus to the market. Additionally, continuous research and development, as well as increasing investments in the launch of advanced wound care products are likely to bolster growth in the coming years.

On the contrary, high treatment costs and the presence of limited or no reimbursement policies, especially in the underdeveloped nations, may challenge the growth of the market. Nevertheless, the advent of bioactive therapy for treating chronic wounds is expected to create a lucrative growth opportunity for the market in the coming years.

 Segment:

Advanced Wound Dressing Segment to earn Largest Share Owing to Better Product Offering

Based on segmentation by type, the advanced wound dressing segment earned 42.6% wound care market share in 2019 and emerged dominant. This is owing to the presence of a diverse product portfolio.

Fortune Business Insights offers a detailed overview of the global market in a report, titled “Wearable Medical Devices Market” Size, Share and Industry Analysis by Product (Diagnostic & Patient Monitoring, Therapeutic), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and, Regional Forecast 2019-2026.” As per the report, the market was valued at USD 24571.8 Million in 2018 and is anticipated to reach USD 139353.6 Million by 2026. The report offers a comprehensive overview of the market drivers, trends, opportunities, and other aspects of the market.

To Gain More Insights into the Market, Click Here: https://www.fortunebusinessinsights.com/industry-reports/wearable-medical-devices-market-101070

List Top Companies Covered in Wearable Medical Devices Market are

• Ypsomed AG
• Sonova
• Hologic Inc.
• Siemens Healthcare GmbH
• AiQ Smart Clothing
• NeuroMetrix, Inc.
• Apple Inc.
• SAMSUNG
• Fitbits
• SugarBeat

The global wearable medical devices market is anticipated to exhibit an exponential CAGR of 24.7% through the forecast years. The healthcare industry is revolutionizing owing to the rising adoption of connected devices. As digital technology is gaining immense popularity, wearable medical devices are evolving rapidly in the healthcare sector.

Moreover, the objective of these devices is to not only promote the overall body fitness but to offer active treatment regarding health conditions. From Fitbit to smartwatches, the market is increasingly driven by technological developments with focus on personalized care. Taking about personalized care, technologies such as internet of things (IoT), cloud computing, and others help in retrieving patient data in real-time, thereby allowing physicians to detect the patient’s health condition in advance.  

Request a Sample Copy of the Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wearable-medical-devices-market-101070

In addition to this, it provides valuable information on mergers and acquisitions, product launches, partnerships, and other strategic activities adopted by global players. Several estimations and projections for the leading geographies are also included in the report. All the above information can help our readers to gain valuable insights into the market, thereby helping them to make the right decision before investing in the market.    

As per product, the diagnostic and monitoring wearable devices segment is expected to hold a major portion of the wearable medical devices market share. The wearable devices market size is expected to surge owing to the rising demand from online pharmacies, retail pharmacies, and other distribution channels. As per current market trends, wearable medical devices are increasingly used by home patients owing to their convenience and ease of use.

Against this backdrop, the demand for these devices is expected to increase, which in turn, will contribute towards the wearable devices market growth.   

Table of Content from Wearable Medical Devices Market:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • Recent Industry Developments- Partnerships, Mergers, and Acquisitions
  • Key Industry Trends
  • New Product Launch by Key Players
  • Technological advancements in Wearable Medical Devices Market

 Rising prevalence of chronic wounds and increasing availability of advanced wound dressings are propelling the growth of advanced wound dressings market says Fortune Business Insights in a published report titled “Advanced Wound Dressings Market Size, Share and Global Trend By Product Type (Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025.”Global advanced wound dressings market to grow at significant a CAGR of 4.6% From 2018-2025, owing to the constant focus of key players on R&D to launch new products.

some of the key players in the global Advanced Wound Dressings Market:

• Derma Sciences Inc.
• Coloplast Corp
• ConvaTec Inc.
• Tissue Regenix
• Mölnlycke Health Care AB
• Smith & Nephew
• Organogenesis Inc.
• KCI Licensing, Inc

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/advanced-wound-dressings-market-100384

Innovations in Advanced Wound Dressing Will Support Growth

Shifting preference of healthcare practitioners from old-fashioned wound dressing to advanced wound dressing has led to the expansion of advanced wound dressing market. The demand for advanced dressing for managing and treating wounds such as diabetic, lower limb ulcers, foot ulcers, pressure ulcers and others are fuelling demand for advanced wound dressing in the healthcare sector. Rising prevalence of surgical wounds and chronic wounds in developing countries is further fuelling the demand and enabling the growth of the global advanced wound dressings market. Launch of advanced products by the key player is also supporting the growth of advanced wound dressings. The product launch by companies with an aim to offer better comfort and quicker healing to patients with chronic wounds such as diabetic foot ulcers, pressure ulcers, skin abrasions, cavity wounds venous leg ulcers donor sites and post-operative surgical wounds. For instance, Axio Biosolutions launched MaxioCel, a new innovation in wound care dressing made of chitson. This product is expected to fuel demand among patients and medical practitioners which will consequently help in the growth of advanced wound dressings market.

Request a Sample Copy of the Global Advanced Wound Dressings Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/advanced-wound-dressings-market-100384

Asia-Pacific to Account for Highest Share in The Global Market

Asia Pacific region was valued at US$ 1,916.0 Mn in 2017 and is predicted to grow at a significantly high CAGR during the forecast period. According to a survey conducted by the United Nations, the Japanese have the highest life expectancy/life-span among all the countries in the world. Besides Japan other countries in Asia Pacific such as India and China also account for a significant share in the global market. The rising prevalence of chronic diseases directing towards longer hospital stays for patients is fostering the growth of the global advanced wound dressings market. Reduced mobility in the region along with rising incidences of chronic diseases are the factors attributing to pressure ulcers and hence enabling growth of the global advanced wound dressings market. Nevertheless, lack of reimbursement policies in Asia Pacific for advanced wound dressings is the factor hampering the growth for advanced wound dressings market.

The global advanced wound dressings market key players are Derma Sciences Inc., Coloplast Corp, ConvaTec Inc., Tissue Regenix, Mölnlycke Health Care AB, Smith & Nephew, Organogenesis Inc., KCI Licensing, Inc, Other Prominent Players

The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period. However, the market was worth USD 8.35 billion in 2018. This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775

Fortune Business Insights lists out some of the renowned companies operating in the contact lenses market. They are as follows:

• Contamac
• CooperVision
• HOYA Corporation
• Essilor
• Bausch & Lomb Incorporated
• Johnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)
• ZEISS International
• Alcon Vision LLC
• Other key market players

Request a Sample Copy of the Global Contact Lenses Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contact-lenses-market-101775

Global Contact Lenses Market Segmentation

By Modality

• Reusable
• Disposable

By Design

• Toric
• Multifocal
• Spherical

By Distribution Channel

• Retail Stores
• Online Stores
• Ophthalmologists

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

What Does the Report Contain?

• In-depth information regarding all the possible segments, including modality, design, distribution channel, and region.
• Elaborate analysis of several insights, namely, contact lenses market trends, opportunities, growth drivers, and hindrances.
• Latest industry developments, such as new product launches, mergers, acquisitions, partnerships, and agreements.

Rising Prevalence of Ocular Disorders to Augment Market Growth

The World Health Organization (WHO) stated that approximately 1.7 million people are affected by presbyopia and around 153 million people reside with uncorrected refractive errors around the world. A rising prevalence of presbyopia worldwide is one of the main factors propeling the contact lenses market growth in the coming years. Also, many people are affected by ocular disorders, which in turn, is expected to boost growth of the market.

Bausch & Lomb Unveils Ultra Multifocal for Astigmatism Contact Lenses

June 2019: Bausch & Lomb Incorporated, an eye health products company, headquartered in New York, announced the launch of its Bausch + Lomb Ultra contact lenses. It is a multifocal lens for astigmatism. The new silicon hydrogel lens was initially created for those affected by both presbyopia and astigmatism. It blends the company’s stability of OpticAlign toric design with its unique 3-Zone Progressive multifocal design to offer professionals and patients an innovative technology.

The global spinal fusion devices market is projected to reach USD 8.45 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period. A rapidly rising global geriatric population will be a critical factor driving the growth of this market. According to the United Nations, around 16% of the world’s population will be over the age of 65 by 2050. In North America and Europe, close to 25% of the population will be aged. Aged people are highly vulnerable to various kinds of injuries and spinal cord injuries are one of the most common afflictions of old age. For instance, a study published in the Lancet journal showed that in the US, the average age of patients who suffered from spinal cord damage rose from 40 years to 50 years in just two decades. This shows that as geriatric population increases, the risk of spinal cord injuries also rises in tandem, thereby spiking the demand for spinal arthrodesis devices in the long-run.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/spinal-fusion-devices-market-101689

Fortune Business Insights identifies some of the prominent competitors in this market:

• DePuy Synthes (Johnson & Johnson Services, Inc.)
• Aesculap, Inc. (B. Braun Melsungen AG)
• Stryker
• Alphatec Spine, Inc.
• RTI Surgical Holdings, Inc.
• Zimmer Biomet
• Medtronic
• NuVasive, Inc.

According to a new report published by Fortune Business Insights, titled “Spinal Fusion Devices Market Size, Share & Industry Analysis, By Product Type (Cervical Devices, Thoracolumbar Devices, Interbody Devices, and Biologics), By Disease Indication (Degenerative Disc Disease, Complex Deformity, Traumas & Fractures, and Others), By End User (Hospitals & Ambulatory Surgery Centers, Specialty Clinics and Others) and Regional Forecast, 2019-2026”, the market value stood at USD 6.37 billion in 2018. Within the report is also contained an exhaustive evaluation and analysis of the drivers, restraints, and other dynamics that will influence the market in the forecast period. Besides this, the report also provides a macroscopic overview of the general industry trends that will enable businesses to align their strategies with the needs of the market.

Request a Sample Copy of the Global Spinal Fusion Devices Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/spinal-fusion-devices-market-101689

A spinal fusion device or implant is an orthopedic surgical mechanism which is used to join or keep in place two or more vertebrae. They consist of interbody devices, biologics, cervical fixation devices, and thoracolumbar fixation devices.

Growing Adoption of Surgical Robots for Spinal Injuries to Prove Favorable for the Market

There is an increasing demand for minimally invasive surgical procedures, prompting many hospitals to adopt robots for performing surgical procedures for the spinal treatments. As a result, manufacturers are now increasingly engaging in developing novel robotic technologies to aid surgeons perform tricky spinal cord surgeries with greater ease and accuracy. Thus, emergence of robotics in healthcare is, therefore, expected to shape the spinal fusion devices market trends during the forecast period.

Some major points from Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Prevalence of Key Spinal Diseases – For Key Countries/Regions
   • Regulatory Scenario – For Key Countries/Regions
   • Reimbursement Scenario – For Key Countries/Regions
   • New Product Launches
   • Key industry Developments – Mergers, Acquisitions and Partnerships
   • Key Industry Trends

The launch of the vaccine named, Vanguard CIV H3N2/H3N8 Vaccine, was announced in December 2017 by Zoetis. This was the most recent vaccine in the list of the company’s canine influenza vaccine portfolio. Such initiatives taken by companies towards the launch of vaccines to protect animals from various diseases is promoting the growth of the global veterinary vaccines market, predicts Fortune Business Insights in their new report.

Launch of Novel Vaccines for the Preventive Care of Animals to Enable Growth in Market

As per the report, the market highlights some of the major shareholders in the veterinary ultrasound devices market. These companies are mentioned below:

• NEOGEN CORPORATION
• Eli Lilly and Company
• Elanco
• Merial
• ImmuCell Corporation
• Ceva
• Intervet Inc. (Merck Animal Health)
• Boehringer Ingelheim International GmbH
• Virbac

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/veterinary-animal-vaccines-market-101532

Fortune Business Insights foresees the global market for veterinary vaccines to rise because of the increasing number of pet adopters worldwide. In a report, titled “Veterinary Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026” it offers an overview of the market, highlighting the key growth drivers and potential restraints. It also provides recommendations to help market players gain competitive edge.

According to the report, the market is anticipated to rise from a value of USD 9.75 Billion in 2018 to USD 16.01 Billion by 2026. The forecast period is set from 2019 to 2026 and the market is expected to rise at a CAGR of 6.4%.

Request a Sample Copy of the Global Veterinary Vaccines Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/veterinary-animal-vaccines-market-101532

The global veterinary vaccines market is segmented on the basis of product, animal, and route of administration, distribution channel, and geography. Among these, the parental animal vaccines segment will earn the highest revenue in the forecast duration with respect to route of administration. This is owing to the fact that parental animal vaccines are among the most traditional and common forms of vaccinations. On the other side, the companion animal segment is prognosticated to grow at rapid CAGR in the forecast period, with respect to animal. This is attributable to the rise in number of pet ownership on a worldwide basis.

Increasing Awareness About Diseases Contracted from Animals by Humans to Fuel Demand for Veterinary Vaccines

The rise in awareness about importance of veterinary healthcare is a major factor boosting the global veterinary vaccines market. The increase in the number of pet owners worldwide is also anticipated to help the market gain traction. Increasing investments in research and development by manufacturers for development of novel veterinary vaccines are also anticipated to promote the global veterinary vaccines market growth during the forecast period. Moreover, the prevalence of diseases that can pass on to humans from animals such as trichinella spiralis, rabies, and others may also help in the veterinary vaccines market growth.

The global contraceptive pills market size is projected to reach USD 20.55 billion by 2026, exhibiting a CAGR of 5.8% during the forecast period. High degree of unfulfilled contraceptive needs in rural areas in emerging economies is expected to be one of the key drivers for the growth of this market. Data gathered under the Demographic and Health Surveys (DHS) conducted between 2005 and 2014 in 52 developing countries revealed that around 8% to 38% of married rural women, aged between 15 and 49 years, faced unmet contraceptive needs. The main reason for this gap is the lack of accessibility and local availability of birth-control pills in these areas. To counter this, governments in many developing and underdeveloped countries are taking efforts to make these modern day medications more accessible and affordable to the rural populace. This will effectively accelerate the oral contraceptives market growth during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-pills-market-101802

Top Players Identified in the Contraceptive Pills Market Report by Fortune Business Insights™:

• Janssen Pharmaceutical Company
• Piramal Enterprises
• Allergan, plc
• Mylan N.V.
• Pfizer, Inc.
• Bayer AG
• Teva Pharmaceutical Industries
• HLL Lifecare Limited
• Merck & Co., Inc.

Increasing Popularity of Advanced Contraceptives to Propel the Market in North America

North America is slated to dominate the contraceptive pills market share, since the region generated USD 4.09 billion in revenue in 2018. The primary reason for this is the rising uptake of short-acting reversible contraceptives in the U.S. and patient-friendly reimbursement policies for oral birth-control pills. Europe will emerge as the second leading region in this market, led by France which has the highest birth rate in the region. Better reimbursement policies will also bode well for the market in Europe. Asia-Pacific will record the fastest growth owing to rising number of awareness drives conducted by the government and NGOs. In Latin America, the Middle East, and Africa, increasing presence of big pharmaceutical companies and growing literacy rates will drive the market in these regions.  

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-pills-market-101802

Exciting Opportunities Await Local and Regional Players in the Market

While big companies such as Bayer AG are benefiting owing to their well-established presence, smaller players operating at the local and regional level are also slowly gaining ground in this market. This is a result of launching of innovative products by these players along with certain capacity restrictions hounding the large players.

TOC:

1. Introduction

1.1. Research Scope

1.2. Market Segmentation

1.3. Research Methodology

1.4. Definitions and Assumptions

2. Executive Summary
3. Market Dynamics

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities

4. Key Insights

4.1 Fertility Statistics (2018)

4.2 Regulatory scenario for key countries

4.3 Recent industry developments such as mergers & acquisitions

4.4 Key Industry Trends

4.5 Government policies & their impact on contraceptives industry

4.6 New Product Launches

5. Global Contraceptive Pills Market Analysis, Insights and Forecast, 2015-2026

5.1. Key Findings / Summary

5.2. Market Analysis, Insights and Forecast – By Type

5.2.1 Combined Contraceptives (E+P)

5.2.2 Progestin-only Pills

5.3. Market Analysis, Insights and Forecast – By Distribution Channel

5.3.1 Hospital Pharmacy

TOC Continued…